FINABASE ON MOBILE

Finabase in your pocket

Live quotes, watchlists and price alerts wherever the market moves.

Get the app

Available for iPhone, iPad and Android

  • Markets

    Markets

    • Overview Indexes, movers, sectors and news
    • Indices World indexes, live
    • Sectors Breadth and rankings by sector
    • Heatmap The market sized by cap
    • Performers Top gainers and losers
    • Trending Most active right now
    • Earnings The earnings calendar
    • Dividends Upcoming ex-dividend dates
    • Crypto Coins and tokens, 24/7
    • Forex Currency pairs
    • Futures Index, energy and metal futures
    • Treasury Yields across the curve
    All markets
  • Research

    Research

    • Screener Filter stocks by any metric
    • Scanner Today's technical signals
    • Trend Score Rank trend strength
    • Insider trading Form 4 buys and sales
    • Compare Side-by-side symbols
    • Options Chains and watched options
    • Backtest Test an indicator rule
    • Strategy Build rule-based allocations
    • Chart settings Your chart templates
    All research
  • News

    News

    • News Headlines as they break
    • Discover Stories by topic
    All news
  • Learn
  • Paper trading
  • AI Chat
/
Get the app Watchlists Portfolios Alerts Sign in Get started
Menu

Markets

  • Overview
  • Indices
  • Sectors
  • Heatmap
  • Performers
  • Trending
  • Earnings
  • Dividends
  • Crypto
  • Forex
  • Futures
  • Treasury

Research

  • Screener
  • Scanner
  • Trend Score
  • Insider trading
  • Compare
  • Options
  • Backtest
  • Strategy
  • Chart settings

News

  • News
  • Discover
Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in
J

jhandy

1 post

Sign in to follow

Posts (1)

J jhandy ETON Sep 16, 2020 · 6 years ago #1

https://www.globenewswire.com/news-release/2020/09/16/2094582/0/en/Eton-Pharmaceuticals-Provides-Update-on-the-FDA-Review-of-EM-100.html

Available on

Take Stock Master With You

Real-time quotes, AI insights, and portfolio tracking on the go.

Download on the App Store Get it on Google Play

Professional-grade financial analysis for stocks, options, and crypto. Powered by AI-driven insights and real-time market data.

Markets

  • Overview
  • Indices
  • Sectors
  • Heatmap
  • Performers
  • Trending
  • Earnings
  • Dividends

Assets

  • Crypto
  • Forex
  • Futures
  • Treasury
  • News
  • Discover

Research

  • Screener
  • Scanner
  • Trend Score
  • Insider trading
  • Compare
  • Options
  • Backtest
  • Strategy
  • Chart settings

Your Finabase

  • AI Chat
  • Watchlists
  • Portfolios
  • Alerts
  • Paper trading
  • Plans & pricing
  • Get the app

Learn

  • Finabase Learn
  • Investing basics
  • Technical indicators
  • Candlestick patterns

Company

  • Why Finabase
  • About us
  • Contact
  • Feedback
  • Privacy
  • Terms
  • Delete my data

Risk disclosure All investing involves risk, including the possible loss of principal. Past performance does not guarantee future results. Options and cryptocurrency trading involve substantial risk and are not appropriate for all investors. Market data is provided for informational purposes only and should not be construed as investment advice. Finabase is not a registered broker-dealer or investment advisor.

© 2026 Finabase. All rights reserved.